Ekso Bionics Holdings Inc (EKSO)
1.17
-0.01
(-0.85%)
USD |
NASDAQ |
May 31, 16:00
1.17
0.00 (0.00%)
After-Hours: 20:00
Ekso Bionics Holdings Cash from Financing (Quarterly): 3.657M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 3.657M |
| December 31, 2023 | 0.348M |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | 0.00 |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 38.71M |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 2.544M |
| June 30, 2020 | 8.749M |
| March 31, 2020 | -0.589M |
| December 31, 2019 | 4.269M |
| September 30, 2019 | -0.598M |
| June 30, 2019 | 8.599M |
| March 31, 2019 | 6.769M |
| December 31, 2018 | -0.104M |
| September 30, 2018 | 3.371M |
| June 30, 2018 | -0.595M |
| Date | Value |
|---|---|
| March 31, 2018 | -0.399M |
| December 31, 2017 | 0.109M |
| September 30, 2017 | 31.54M |
| June 30, 2017 | 10.92M |
| March 31, 2017 | 0.002M |
| December 31, 2016 | 8.77M |
| September 30, 2016 | 14.71M |
| June 30, 2016 | -0.008M |
| March 31, 2016 | -0.164M |
| December 31, 2015 | 14.03M |
| September 30, 2015 | 0.01M |
| June 30, 2015 | 0.03M |
| March 31, 2015 | 0.052M |
| December 31, 2014 | 21.40M |
| September 30, 2014 | 0.04M |
| June 30, 2014 | -0.0387M |
| March 31, 2014 | 19.48M |
| December 31, 2013 | 0.0015M |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | -0.0005M |
| December 31, 2012 | 0.019M |
| September 30, 2012 | 0.0088M |
| June 30, 2012 | 0.0054M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.598M
Minimum
Sep 2019
38.71M
Maximum
Mar 2021
4.692M
Average
0.174M
Median
Cash from Financing (Quarterly) Benchmarks
| Vicarious Surgical Inc | 0.002M |
| Perspective Therapeutics Inc | 166.33M |
| Xtant Medical Holdings Inc | 5.179M |
| Asensus Surgical Inc | 0.811M |
| Catheter Precision Inc | -0.11M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.466M |
| Cash from Investing (Quarterly) | -0.008M |
| Free Cash Flow | -11.43M |
| Free Cash Flow Per Share (Quarterly) | -0.1994 |
| Free Cash Flow to Equity (Quarterly) | -3.236M |
| Free Cash Flow Yield | -65.58% |